liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Suppression of macrophage activation with CNI-1493 increases survival in infant rats with systemic Haemophilus influenzae infection
Division of Infectious Diseases, Department of Medicine, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
Division of Infectious Diseases, Department of Medicine, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
Division of Infectious Diseases, Department of Medicine, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
Division of Infectious Diseases, Department of Medicine, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
Show others and affiliations
2000 (English)In: Infection and Immunity, ISSN 0019-9567, E-ISSN 1098-5522, Vol. 68, no 9, 5329-5334 p.Article in journal (Refereed) Published
Abstract [en]

CNI-1493, a potent macrophage deactivator, was used to treat infant rats systemically infected with Haemophilus influenzae type b (Hib). CNI-1493 was injected 1 h prior to bacterial inoculation and 24 h later and resulted in a 75 percent increased rate of survival compared to that for untreated controls. The effect of CNI-1493 on the inflammatory response was studied by immunohistochemical detection of individual tumor necrosis factor alpha (TNF-α)-, interleukin 1 beta (IL-1β)-, and gamma interferon (IFN-γ)-producing cells in the spleen. A significant reduction of the incidence of TNF-α- and IL-1β-expressing cells was found for CNI-1493-treated animals. IFN-γ expression was not suppressed by CNI-1493, indicating that cytokine inhibition was specific in macrophages. CNI-1493 significantly reduced the number of infiltrating granulocytes in the brain from that for controls. This study provides evidence that CNI-1493 protects against lethal Hib infection by deactivating the inflammatory cascade in infant rats.

Place, publisher, year, edition, pages
2000. Vol. 68, no 9, 5329-5334 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-81948DOI: 10.1128/​IAI.68.9.5329-5334.2000OAI: oai:DiVA.org:liu-81948DiVA: diva2:556759
Available from: 2012-09-26 Created: 2012-09-26 Last updated: 2017-12-07Bibliographically approved
In thesis
1. Modulation of inflammatory mediators during experimental bacterial meningitis
Open this publication in new window or tab >>Modulation of inflammatory mediators during experimental bacterial meningitis
2005 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Bacterial meningitis is a worldwide health problem with high morbidity and mortality mainly caused by Haemophilus influenzae, Neisseria meningitidis and Streptococcus pneumoniae. It is an inflammatory disease of the central nervous system (eNS) initiated by cell wall or membrane components from the bacteria. This stimulates an accumulation of polymorphonuclear leukocytes (PMN) in the subarachnoid space, where they are further stimulated by bacterial products or by cytokines to release inflammatory mediators including nitric oxide (NO) and chemokines. The role of these mediators in the inflammatory response in vivo is not fully understood. The aim of present thesis was to investigate the role of these inflammatory mediators using Haemophilus influenzae type b (Hib) in an experimental model for meningitis.

Intraperitoneal inoculation of Hib into infant rats resulted in induction of iNOS mRNA that was detected in brain sections 12 hr post-inoculation (p.i). The number of iNOS mRNA-containing cells was gradually reduced and normalized by day 7 p.i. The numbers of intracerebral iNOS expressing cells was also detected after 12h p.i., but they were further elevated to a peak at 72h p.i. The iNOS positive brain sections also bound antibody specific for nitrotyrosine.

Brains of infant rats challenged intraperitoneally with Hib resulted in a time-dependent expression of MIP-2, MIP-1α MCP-1 and RANTES, which were detected with maximum levels at 24-48 h p.i. There were significant increases in the number of neutrophils and macrophages in the meninges, the ventricular system and the periventricular area. The kinetics of MIP-2, MIP-α, MCP-1 and RANTES mRNA expression paralleled those of the recruitment of inflammatory cells and disease severity. Administration of anti-MIP-2 or anti-MIP-1α antibodies (Abs) reduced the number of infiltrated neutrophils, anti-MCP-1 Abs reducing macrophage infiltration.

Hib infection resulted in 100% mortality by 72 h p.i. and pretreatment with CNI-1493, a tetravalent guanylhydrazone, resulted in 75% survival. This treatment also reduced the number of infiltrating granulocytes in the brain and reduced the number of cells producing TNF-α and IL-Iß in the spleen.

Macrophages (RAW 246.7) preincubated with CNI-1493 prior to activation with LPS/IFN- γ had decreased NO production and reduced iNOS expression. The production of reactive oxygen species (ROS) was increased in FMLP-stimulated granulocytes following CNI-1493-treatment, whereas their F-actin content, motility and chemotaxis were decreased under the same condition.

Conclusion: During experimental Hib meningitis iNOS was upregulated and associated with NO production. The chemokines MIP-2, MIP-1α MCP and RANTES were expressed and shown to be involved in neutrophil recruitment in vivo. Blockade of MIP-2 or MIP-1α bioactivity in vivo resulted in decreased neutrophil influx. CNI-1493 treatment increased animal survival by attenuating CNS inflammation and in vitro CNI-1493 had a direct effect on both macrophages and PMN.

Place, publisher, year, edition, pages
Linköping: Linköping University Electronic Press, 2005. 40 p.
Series
Linköping University Medical Dissertations, ISSN 0345-0082 ; 907
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-30081 (URN)15546 (Local ID)91-8529914-6 (ISBN)15546 (Archive number)15546 (OAI)
Public defence
2005-06-09, Eken, Hälsouniversitetet, Campus US, Linköpings universitet, Linköping, 09:00 (English)
Opponent
Available from: 2009-10-09 Created: 2009-10-09 Last updated: 2012-09-26Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Abdalla, Hana

Search in DiVA

By author/editor
Abdalla, Hana
In the same journal
Infection and Immunity
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 121 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf